PIONEER MEDICAL GROUP
ARDENTON WALK, BRISTOL
Stroke 12
The % of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| STROKE 9 | 2005 | 77 | 84 | 91.7% | |
| STROKE 9 | 2006 | 76 | 79 | 96.2% | |
| Stroke 12 | 2007 | 85 | 88 | 96.6% | |
| Stroke 12 | 2008 | 83 | 86 | 96.5% | |
| Stroke 12 | 2009 | 88 | 95 | 92.6% | |
| Stroke 12 | 2010 | 82 | 90 | 91.1% | |
| STROKE 12 | 2011 | 94 | 104 | 90.4% | |
| STROKE 12 | 2012 | 90 | 100 | 90.0% | |
| STROKE 12 | 2013 | 93 | 102 | 91.2% | |
| STIA007 | 2014 | 88 | 90 | 97.8% | |
| STIA007 | 2015 | 100 | 103 | 97.1% | |
| STIA007 | 2016 | 101 | 107 | 94.4% | |
| STIA007 | 2017 | 210 | 222 | 94.6% | |
| STIA007 | 2018 | 210 | 215 | 97.7% | |
| STIA007 | 2019 | 206 | 221 | 93.2% | |
| STIA007 | 2020 | 195 | 207 | 94.2% | |
| STIA007 | 2021 | 218 | 242 | 90.1% | |
| STIA007 | 2022 | 228 | 230 | 99.1% | |
| STIA007 | 2023 | 245 | 264 | 92.8% |
